| Name | Title | Contact Details |
|---|---|---|
Jennifer McAleer |
Chief Compliance and Privacy Officer | Profile |
BGHS is a state-licensed, non-profit behavioral healthcare provider located in Ansonia, CT, serving the citizens of the Lower Naugatuck Valley and surrounding communities. One out of every five Americans suffers from some form of mental illness. Each
SciMar is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Medifast, Inc. is a leading provider of clinically proven, doctor-recommended weight-loss and live healthy solutions. The companys product portfolio includes Medifast 5 & 1 Plan, OPTAVIA Coach-led Optimal Weight 5 & 1 Plan, Thrive by Medifast, and mor...
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.
As one of the world`s premier cancer centers, Memorial Sloan Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and the biomedical research agenda around the world.